Croatia vs Latin America and the Caribbean: Percentage of bloodstream infection due to methicillin-resistant
Croatia
53.8%
in 2022
Latin America and the Caribbean
39.0%
in 2022
Croatia rank
9th
Latin America and the Caribbean rank
10th
Percentage of bloodstream infection due to methicillin-resistant over time
- Croatia
- Latin America and the Caribbean
How they compare
Croatia currently reports 53.8% against 39.0% in Latin America and the Caribbean, a difference of 14.8%.
That makes Croatia's figure about 1.4 times Latin America and the Caribbean's.
The two have swapped places 1 time across 6 shared years of data; in 2017 it was Latin America and the Caribbean ahead.
Croatia ranks 9th and Latin America and the Caribbean ranks 10th of 50 countries.
Across the 2 decades both report, Croatia averaged higher in 1 and Latin America and the Caribbean in 1.
Head to head by decade
| Decade | Croatia | Latin America and the Caribbean | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 26.6% | 39.2% | 12.6% | Latin America and the Caribbean |
| 2020s | 56.8% | 40.5% | 16.3% | Croatia |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher percentage of bloodstream infection due to methicillin-resistant, Croatia or Latin America and the Caribbean?
- Croatia, at 53.8% against 39.0% in Latin America and the Caribbean as of 2022.
- What is the difference in percentage of bloodstream infection due to methicillin-resistant between Croatia and Latin America and the Caribbean?
- 14.8%, with Croatia ahead.
- How many years of comparable data are there for Croatia and Latin America and the Caribbean?
- 6 years are reported by both, from 2017 to 2022.
- How do Croatia and Latin America and the Caribbean rank globally for percentage of bloodstream infection due to methicillin-resistant?
- Croatia ranks 9th and Latin America and the Caribbean ranks 10th of 50 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Percentage of bloodstream infection due to methicillin-resistant Staphylococcus aureus (MRSA) among patients seeking care and whose blood sample is taken and tested (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.